We are live on ! Find out more
RNAC icon

Cartesian Therapeutics
RNAC

68 hedge funds and large institutions have $119M invested in Cartesian Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 9

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

8% more capital invested

Capital invested by funds: $110M → $119M (+$9.13M)

6% more funds holding

Funds holding: 64 → 68 (+4)

2.84% less ownership

Funds ownership: 28.75% → 25.91% (-2.8%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
68
Holders Change
+4
Holders Change %
+6.25%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
30
Reduced
9
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.78M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.77M
3
MB
MPM BioImpact
Massachusetts
+$1.86M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.73M
5
6CM
683 Capital Management
New York
+$1M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.68M
2
GPP
Great Point Partners
Connecticut
-$3.22M
3
YU
Yale University
Connecticut
-$1.61M
4
AC
Armistice Capital
New York
-$1.59M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
51
Osaic Holdings
Arizona
$3.04K -$1.3K -64 -27%
AB
52
Amalgamated Bank
New York
$2K – – –
Daiwa Securities Group
53
Daiwa Securities Group
Japan
$2K +$1.7K +84 New
AWM
54
Activest Wealth Management
Florida
$1.18K – – –
Carson Wealth (CWM LLC)
55
Carson Wealth (CWM LLC)
Nebraska
$1K +$1.3K +64 +400%
SWM
56
Spire Wealth Management
Virginia
$896 +$1.01K +50 New
SS
57
SBI Securities
Japan
$878 +$992 +49 New
Nisa Investment Advisors
58
Nisa Investment Advisors
Missouri
$860 +$749 +37 +336%
National Bank of Canada
59
National Bank of Canada
Quebec, Canada
$716 +$810 +40 New
WWP
60
WR Wealth Planners
Missouri
$591 +$3.93K +194 +497%
FFA
61
Farther Finance Advisors
California
$322 – – –
SCM
62
Sterling Capital Management
North Carolina
$251 +$142 +7 +100%
WCM
63
WealthTrak Capital Management
Virginia
$180 +$202 +10 New
TC
64
Truvestments Capital
Florida
$179 +$202 +10 New
SIM
65
Synergy Investment Management
Florida
$107 +$121 +6 New
PA
66
Parallel Advisors
California
$54 – – –
IA
67
IFP Advisors
Florida
$18 +$20 +1 New
GPP
68
Great Point Partners
Connecticut
– -$3.22M -200,000 Closed
YU
69
Yale University
Connecticut
– -$1.61M -100,000 Closed
AC
70
Armistice Capital
New York
– -$1.59M -98,565 Closed
SSA
71
Schonfeld Strategic Advisors
New York
– -$798K -50,000 Closed
Balyasny Asset Management
72
Balyasny Asset Management
Illinois
– -$798K -49,497 Closed
LSAG
73
Lake Street Advisors Group
New Hampshire
– -$255K -15,822 Closed
IIM
74
Ironwood Investment Management
Massachusetts
– -$236K -14,631 Closed
BCM
75
Bridgeway Capital Management
Texas
– -$164K -10,193 Closed
1 2
3
4

RNAC Hedge Fund Activity: Q4 2024 in Review

68 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Cartesian Therapeutics (RNAC) for Q4 2024, worth a combined $119M — up 8.3% from $110M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new RNAC positions and 11 closed out — a net gain of 4 holders — while 30 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $4.78M. The largest seller was Fidelity Investments, cutting an estimated $8.68M.

  • 68 institutional investors held Cartesian Therapeutics (RNAC) as of Q4 2024, up from 64 in Q3 2024.
  • Funds reported $119M of Cartesian Therapeutics stock for Q4 2024, up 8.3% quarter-over-quarter.
  • 15 funds opened new Cartesian Therapeutics positions in Q4 2024 and 11 closed out, a net change of +4 holders.
  • The largest Cartesian Therapeutics buyer in Q4 2024 was BlackRock, an estimated $4.78M added.
  • The largest Cartesian Therapeutics seller in Q4 2024 was Fidelity Investments, an estimated $8.68M sold.

Based on aggregated 13F filings for Q4 2024.